Understanding of Psychotic Disorders in Children With 22q11.2DS
Condition22q11.2 Deletion Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-13
SponsorHôpital le Vinatier
About this trial
The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome
Eligibility criteria
Qualifiers
Diagnosis of 22q11.2 deletion syndrome or no developmental disease
Aged from 4 to 13 years old
French language
Disqualifiers
Diagnosis of intellectual deficiency according to DSM 5 criteria
Drug prescribed for somatic condition that could influence cerebral functioning
Trial design
Treatments tested in this trial
- neuropsychological testing, questionnaires and experimental tasks
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov